Liyun Miao

2.8k total citations
76 papers, 1.1k citations indexed

About

Liyun Miao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Liyun Miao has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Liyun Miao's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers). Liyun Miao is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers). Liyun Miao collaborates with scholars based in China, United States and Taiwan. Liyun Miao's co-authors include Hourong Cai, Yonglong Xiao, Yong Song, Hourong Cai, Deping Zhang, Jingjing Ding, Yongsheng Wang, Hongping Xia, Qi Zhao and Hui Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Liyun Miao

74 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liyun Miao China	21	515	346	341	332	94	76	1.1k
Cinzia Bagalá Italy	18	629 1.2×	484 1.4×	177 0.5×	198 0.6×	104 1.1×	36	1.3k
Esra Gündüz Japan	21	858 1.7×	397 1.1×	161 0.5×	240 0.7×	88 0.9×	70	1.3k
Kun-Tu Yeh Taiwan	23	866 1.7×	438 1.3×	184 0.5×	346 1.0×	115 1.2×	43	1.4k
Riku Katainen Finland	18	618 1.2×	280 0.8×	189 0.6×	287 0.9×	142 1.5×	33	1.6k
Yang Zong United States	16	534 1.0×	406 1.2×	467 1.4×	215 0.6×	89 0.9×	32	1.2k
V. Costantini Italy	18	244 0.5×	268 0.8×	232 0.7×	248 0.7×	108 1.1×	35	1.1k
Young A. Yoo South Korea	17	887 1.7×	462 1.3×	201 0.6×	247 0.7×	61 0.6×	28	1.3k
Yeqing Yuan China	18	434 0.8×	164 0.5×	154 0.5×	146 0.4×	59 0.6×	38	921
Heinz‐Joachim Radzun Germany	15	488 0.9×	235 0.7×	145 0.4×	137 0.4×	88 0.9×	38	1.0k
Mian He China	18	1.1k 2.2×	220 0.6×	98 0.3×	811 2.4×	104 1.1×	41	1.7k

Countries citing papers authored by Liyun Miao

Since Specialization

Citations

This map shows the geographic impact of Liyun Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyun Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyun Miao more than expected).

Fields of papers citing papers by Liyun Miao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyun Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyun Miao. The network helps show where Liyun Miao may publish in the future.

Co-authorship network of co-authors of Liyun Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Liyun Miao. A scholar is included among the top collaborators of Liyun Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyun Miao. Liyun Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Lin, Yinghua Ji, Gongyan Chen, et al.. (2025). Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial. The Lancet Respiratory Medicine. 13(8). 677–686. 2 indexed citations

Liu, Yiqian, Liyun Miao, Xiao Chen, et al.. (2024). Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials. Medicine. 103(27). e38459–e38459. 1 indexed citations

Lv, Tangfeng, Qi Zhao, Jia Liu, et al.. (2024). Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice. Infection. 52(2). 625–636. 11 indexed citations

Duan, Jianchun, Jun Zhao, Zhang Li, et al.. (2023). Safety and preliminary efficacy of YK-029A, a novel EGFR TKI, in patients with advanced NSCLC harboring ex20ins, T790M or rare mutations.. Journal of Clinical Oncology. 41(16_suppl). 9014–9014. 2 indexed citations

Wang, Yanning, Qianning Zhang, Chuansheng Chen, et al.. (2021). Association of Brain Metastases With Immune Checkpoint Inhibitors Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 721760–721760. 4 indexed citations

Wang, Yongsheng, Feng Jiang, Ruixue Xia, et al.. (2021). Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis. Frontiers in Oncology. 11. 701171–701171. 8 indexed citations

Wang, Yanning, Liyun Miao, Yuxuan Hu, & Yujie Zhou. (2020). The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 10. 1636–1636. 11 indexed citations

Song, Yong, Liyun Miao, Zhaoxia Wang, & Meiqi Shi. (2020). Combination of apatinib and docetaxel in treating advanced non-squamous non-small cell lung cancer patients with wild-type EGFR: a multi-center, phase II trial. Journal of Thoracic Disease. 12(5). 2450–2458. 8 indexed citations

Chen, Lulu, Xue Han, Yujuan Gao, et al.. (2020). <p>Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable <em>KRAS</em>-Positive Hepatoid Lung Adenocarcinoma: A Case Report and Literature Review</p>. OncoTargets and Therapy. Volume 13. 4359–4364. 21 indexed citations

10.

Miao, Liyun, et al.. (2020). Illumina-based analysis yields new insights into the diversity and composition of endophytic fungi in cultivated Huperzia serrata. PLoS ONE. 15(11). e0242258–e0242258. 16 indexed citations

11.

Zhao, Jun, Gen Lin, Minglei Zhuo, et al.. (2019). Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. Lung Cancer. 141. 114–118. 30 indexed citations

12.

Lin, Zhiwei, Jianwei Gu, Lu Gan, et al.. (2018). The initial deficiency of protein processing and flavonoids biosynthesis were the main mechanisms for the male sterility induced by SX-1 in Brassica napus. BMC Genomics. 19(1). 806–806. 16 indexed citations

13.

Zhao, Jun, Rongrong Chen, Gen Lin, et al.. (2018). Next generation sequencing (NGS) based mutation profiling and heterogeneity of resistance mechanisms to AZD9291.. Journal of Clinical Oncology. 36(15_suppl). 9068–9068. 1 indexed citations

14.

Li, Yan, Liyun Miao, Min Yu, et al.. (2017). α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression. International Journal of Oncology. 50(6). 1955–1964. 26 indexed citations

15.

Chen, Qiufang, Zhenzhen Pan, Min Zhao, et al.. (2017). High cholesterol in lipid rafts reduces the sensitivity to EGFR‐TKI therapy in non‐small cell lung cancer. Journal of Cellular Physiology. 233(9). 6722–6732. 49 indexed citations

16.

Miao, Liyun, Libin Zhang, Nadia Raboanatahiry, et al.. (2016). Transcriptome Analysis of Stem and Globally Comparison with Other Tissues in Brassica napus. Frontiers in Plant Science. 7. 1403–1403. 14 indexed citations

17.

Cheng, Ting, et al.. (2014). Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer. Medical Oncology. 32(1). 407–407. 26 indexed citations

18.

Li, Yan, Liyun Miao, Yonglong Xiao, Hourong Cai, & Deping Zhang. (2014). Elevated Platelets Enhance Cancer Cell Migration, Promote Hematogenous Metastasis and Associate with a Poor Prognosis in Advanced Non-small Cell Lung Cancer Cases. Asian Pacific Journal of Cancer Prevention. 15(1). 139–143. 16 indexed citations

19.

Wang, Yongsheng, Liyun Miao, Lu Liu, et al.. (2013). Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with clinical outcome of erlotinib treatment. Chinese Medical Journal. 126(20). 3931–3935. 8 indexed citations

20.

Miao, Liyun, et al.. (2011). Isolation and Identification of a Taxol-producing Endophytic Fungus YN6. Zhongguo shengwu huaxue yu fenzi shengwu xuebao. 28(12). 1141–1146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact